🇺🇸 FDA
Patent

US 11365413

Inhibition of poly(A) binding protein and the treatment of pain

granted A61KA61K31/7125A61K45/06

Quick answer

US patent 11365413 (Inhibition of poly(A) binding protein and the treatment of pain) held by The Board of Regents of the University of Texas System expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/7125, A61K45/06, A61K9/0014, A61K9/0019